(Q44317851)

1 December 2017

title

Effect of 4-hydroxytamoxifen isomers on growth and ultrastructural aspects of normal human breast epithelial (HBE) cells in culture (English)

1 reference

1 December 2017

Catherine Malet

1

1 reference

1 December 2017

Poli Spritzer

2

1 reference

1 December 2017

Caroline Cumins

3

1 reference

1 December 2017

Delhy Guillaumin

4

1 reference

1 December 2017

Pierre Mauvais-Jarvis

5

1 reference

1 December 2017

Frédérique Kuttenn

6

1 reference

1 December 2017

publication date

1 November 2002

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

1 December 2017

published in

1 reference

1 December 2017

volume

82

1 reference

1 December 2017

issue

4-5

1 reference

1 December 2017

page(s)

289-296

1 reference

Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Hormonal regulation of apoptosis in breast cells and tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Geometric isomers of substituted triphenylethylenes and antiestrogen action

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Facile geometric isomerization of phenolic non-steroidal estrogens and antiestrogens: limitations to the interpretation of experiments characterizing the activity of individual isomers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

17β-Hydroxysteroid Dehydrogenase Activity in Human Breast Epithelial Cell and Fibroblast Cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Estradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblasts: immunocytochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Assay for nanogram quantities of DNA in cellular homogenates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Surface and shape changes during cell division

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Effects of estradiol and promegestone on human breast cell cultures. An ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Etiology of Human Breast Cancer: A Review2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Risk factors for breast cancer in women with proliferative breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

The epidemiology of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Tamoxifen: disease prevention or disease substitution?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Endocrine Consequences of Continuous Antiestrogen Therapy with Tamoxifen in Premenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Lack of induction of endometrial hyperplasia with tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

Ligand interaction at the estrogen receptor to program antiestrogen action: a study with nonsteroidal compounds in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2802%2900226-1

7 January 2021

10.1016/S0960-0760(02)00226-1

Identifiers

DOI

1 reference

1 December 2017

1 reference